Biocon Limited Share Price & Analysis
₹413.45Updated 5 Jun 2026, 03:30 pm IST
LTP
₹413.45
—
Open
₹416.3
High
₹425
Low
₹411.5
Close
₹416.05
52W High
₹440
52W Low
₹328
Volume
2480K
Lot Size
2500
Sector
Healthcare
Market Cap
₹68K Cr
Face Value
₹5
Large CapNIFTY 200NIFTY 500MIDCAP 100
Price Chart
Fundamentals
P/E
174
Sector P/E
48.9
P/B
1.97
EPS
₹4.81
ROE
1.4%
ROCE
3.75%
D/E Ratio
0.45
Div Yield
0.12%
Book Value
₹210
+
Strengths
- ✓Low debt relative to equity (D/E 0.5x)
−
Concerns
- ✗Low capital efficiency (ROCE 3.8%)
- ✗Premium to sector peers (P/E 174x vs industry 48.9x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,783 | ₹4.3L Cr | 34.4 | 5.12 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹6,616 | ₹1.7L Cr | 66.1 | 10.48 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,416 | ₹1.5L Cr | 66.4 | 17.81 | 27.6 | 15.4 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,315 | ₹1.2L Cr | 59.5 | 12.62 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,402 | ₹1.1L Cr | 27.3 | 3.29 | 12.4 | 16.6 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,091 | ₹1.1L Cr | 20 | 4.05 | 21.2 | 21.2 | 0.38 |
| DRREDDY Dr. Reddy's Laboratories Limited | ₹1,283 | ₹1.1L Cr | 25.4 | 2.83 | 11.8 | 13.6 | 0.16 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
BIOCON · as of Mar 2026
Promoters60.64%
FII5.67%
DII15.73%▲0.37
Public17.77%▼0.34
Others0.21%▼0.01
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 60.64% | 60.64% | 60.64% | 60.64% | 60.64% | 60.64% |
| FII | 6.55% | 5.63% | 5.90% | 5.93% | 5.66% | 5.67% |
| DII | 14.51% | 13.69% | 14.29% | 14.44% | 15.36% | 15.73% |
| Public | 17.96% | 19.74% | 18.90% | 18.74% | 18.11% | 17.77% |
| Others | 0.33% | 0.32% | 0.28% | 0.25% | 0.22% | 0.21% |
Corporate Events
Dividend - Re 0.50 Per Share
Dividend2 Jul 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
Dividend6 May 2026
To consider Fund Raising
Event6 May 2026
Dividend - Rs 0.50 Per Share
Dividend3 Jul 2025
Dividend - Re 0.50 Per Share
Dividend4 Jul 2024
Dividend - Rs 1.50 Per Share
Dividend6 Jul 2023
Latest News
All news →Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹4.2K Cr ▼2.9% | ₹4.3K Cr ▲9.0% | ₹3.9K Cr ▼10.8% | ₹4.4K Cr ▲15.6% | ₹3.8K Cr ▲6.4% | ₹3.6K Cr ▲4.6% | ₹3.4K Cr ▼12.4% | ₹3.9K Cr |
| Op. Profit | ₹834 Cr ▼0.1% | ₹835 Cr ▲11.5% | ₹749 Cr ▼30.5% | ₹1.1K Cr ▲43.4% | ₹752 Cr ▲9.8% | ₹685 Cr ▲10.5% | ₹620 Cr ▼32.1% | ₹913 Cr |
| OPM | 20.0% ▲5.3% | 19.0% ▲0.0% | 19.0% ▼20.8% | 24.0% ▲20.0% | 20.0% ▲5.3% | 19.0% ▲5.6% | 18.0% ▼21.7% | 23.0% |
| Net Profit | ₹-52 Cr ▼139.1% | ₹133 Cr ▲49.4% | ₹89 Cr ▼80.6% | ₹459 Cr ▲466.7% | ₹81 Cr ▲200.0% | ₹27 Cr ▼96.9% | ₹862 Cr ▲286.5% | ₹223 Cr |
| EPS (₹) | 1.08 ▲71.4% | 0.63 ▲173.9% | 0.23 ▼92.0% | 2.87 ▲1266.7% | 0.21 ▲261.5% | -0.13 ▼102.4% | 5.49 ▲385.8% | 1.13 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹16.9K Cr ▲10.9% | ₹15.3K Cr ▲3.4% | ₹14.8K Cr ▲32.1% | ₹11.2K Cr ▲36.5% | ₹8.2K Cr ▲14.6% | ₹7.1K Cr ▲13.4% | ₹6.3K Cr ▲14.3% | ₹5.5K Cr ▲33.7% | ₹4.1K Cr ▲6.0% | ₹3.9K Cr |
| Expenses | ₹13.5K Cr ▲12.2% | ₹12.0K Cr ▲4.1% | ₹11.5K Cr ▲31.7% | ₹8.8K Cr ▲37.1% | ₹6.4K Cr ▲14.9% | ₹5.6K Cr ▲18.4% | ₹4.7K Cr ▲14.0% | ₹4.1K Cr ▲25.1% | ₹3.3K Cr ▲13.1% | ₹2.9K Cr |
| Op. Profit | ₹3.5K Cr ▲6.2% | ₹3.3K Cr ▲1.2% | ₹3.2K Cr ▲33.3% | ₹2.4K Cr ▲34.5% | ₹1.8K Cr ▲13.4% | ₹1.6K Cr ▼1.4% | ₹1.6K Cr ▲15.1% | ₹1.4K Cr ▲68.2% | ₹829 Cr ▼15.4% | ₹980 Cr |
| OPM | 20.0% ▼4.8% | 21.0% ▼4.5% | 22.0% ▲0.0% | 22.0% ▲0.0% | 22.0% ▲0.0% | 22.0% ▼12.0% | 25.0% ▲0.0% | 25.0% ▲25.0% | 20.0% ▼20.0% | 25.0% |
| Other Income | ₹-60 Cr ▼104.9% | ₹1.2K Cr ▲42.7% | ₹853 Cr ▲4638.9% | ₹18 Cr ▼75.0% | ₹72 Cr ▼72.3% | ₹260 Cr ▲30.7% | ₹199 Cr ▼41.5% | ₹340 Cr ▲49.1% | ₹228 Cr ▲31.8% | ₹173 Cr |
| Interest | ₹990 Cr ▲10.4% | ₹897 Cr ▼7.9% | ₹974 Cr ▲132.5% | ₹419 Cr ▲516.2% | ₹68 Cr ▲17.2% | ₹58 Cr ▼10.8% | ₹65 Cr ▼8.5% | ₹71 Cr ▲14.5% | ₹62 Cr ▲138.5% | ₹26 Cr |
| Depreciation | ₹2.0K Cr ▲16.0% | ₹1.7K Cr ▲7.5% | ₹1.6K Cr ▲41.0% | ₹1.1K Cr ▲36.7% | ₹814 Cr ▲13.8% | ₹715 Cr ▲29.5% | ₹552 Cr ▲23.2% | ₹448 Cr ▲16.4% | ₹385 Cr ▲39.0% | ₹277 Cr |
| PBT | ₹448 Cr ▼76.3% | ₹1.9K Cr ▲23.7% | ₹1.5K Cr ▲70.0% | ₹897 Cr ▼8.7% | ₹983 Cr ▼8.0% | ₹1.1K Cr ▼9.9% | ₹1.2K Cr ▼2.4% | ₹1.2K Cr ▲99.2% | ₹610 Cr ▼28.2% | ₹850 Cr |
| Tax % | 18.0% ▼25.0% | 24.0% ▲60.0% | 15.0% ▼46.4% | 28.0% ▲27.3% | 22.0% ▲4.8% | 21.0% ▼22.2% | 27.0% ▲58.8% | 17.0% ▼34.6% | 26.0% ▲36.8% | 19.0% |
| Net Profit | ₹369 Cr ▼74.2% | ₹1.4K Cr ▲10.1% | ₹1.3K Cr ▲101.9% | ₹643 Cr ▼16.7% | ₹772 Cr ▼8.7% | ₹846 Cr ▼2.9% | ₹871 Cr ▼13.2% | ₹1.0K Cr ▲121.4% | ₹453 Cr ▼34.2% | ₹688 Cr |
| EPS (₹) | 2.38 ▼71.8% | 8.44 ▼0.9% | 8.52 ▲121.3% | 3.85 ▼28.7% | 5.4 ▼12.5% | 6.17 ▼1.1% | 6.24 ▼17.2% | 7.54 ▲143.2% | 3.1 ▼39.2% | 5.1 |
| Div Payout | 21.0% ▲250.0% | 6.0% ▲0.0% | 6.0% ▼84.6% | 39.0% ▲333.3% | 9.0% | 0.0% | 0.0% ▼100.0% | 7.0% ▼56.3% | 16.0% ▲60.0% | 10.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||||
| Equity Capital | ₹668 Cr ▲11.3% | ₹600 Cr ▲0.0% | ₹600 Cr ▲0.0% | ₹600 Cr ▲0.0% | ₹600 Cr ▲0.0% | ₹600 Cr ▲0.0% | ₹600 Cr ▲100.0% | ₹300 Cr ▲0.0% | ₹300 Cr ▲200.0% | ₹100 Cr |
| Reserves | ₹26.1K Cr ▲24.2% | ₹21.0K Cr ▲9.7% | ₹19.2K Cr ▲11.1% | ₹17.3K Cr ▲120.5% | ₹7.8K Cr ▲11.5% | ₹7.0K Cr ▲15.1% | ₹6.1K Cr ▲5.3% | ₹5.8K Cr ▲18.8% | ₹4.9K Cr ▲3.0% | ₹4.7K Cr |
| Borrowings | ₹16.5K Cr ▼9.9% | ₹18.4K Cr ▲12.8% | ₹16.3K Cr ▼9.7% | ₹18.0K Cr ▲250.1% | ₹5.1K Cr ▲14.9% | ₹4.5K Cr ▲65.0% | ₹2.7K Cr ▲12.1% | ₹2.4K Cr ▲7.0% | ₹2.3K Cr ▼1.7% | ₹2.3K Cr |
| Other Liabilities | ₹19.4K Cr ▲4.8% | ₹18.5K Cr ▼5.9% | ₹19.7K Cr ▲24.2% | ₹15.9K Cr ▲134.5% | ₹6.8K Cr ▲6.0% | ₹6.4K Cr ▲27.8% | ₹5.0K Cr ▲36.0% | ₹3.7K Cr ▲44.3% | ₹2.5K Cr ▲12.9% | ₹2.3K Cr |
| Total Liabilities | ₹62.8K Cr ▲7.2% | ₹58.5K Cr ▲5.0% | ₹55.8K Cr ▲7.8% | ₹51.7K Cr ▲154.4% | ₹20.3K Cr ▲10.0% | ₹18.5K Cr ▲28.3% | ₹14.4K Cr ▲18.2% | ₹12.2K Cr ▲22.0% | ₹10.0K Cr ▲6.3% | ₹9.4K Cr |
| Assets | ||||||||||
| Fixed Assets | ₹37.3K Cr ▲16.6% | ₹32.0K Cr ▲4.3% | ₹30.6K Cr ▲4.0% | ₹29.5K Cr ▲348.6% | ₹6.6K Cr ▲3.2% | ₹6.4K Cr ▲6.6% | ₹6.0K Cr ▲33.5% | ₹4.5K Cr ▲20.8% | ₹3.7K Cr ▲2.0% | ₹3.6K Cr |
| CWIP | ₹4.7K Cr ▼45.3% | ₹8.5K Cr ▲6.4% | ₹8.0K Cr ▲9.2% | ₹7.3K Cr ▲78.0% | ₹4.1K Cr ▲46.8% | ₹2.8K Cr ▲27.5% | ₹2.2K Cr ▲15.6% | ₹1.9K Cr ▲45.7% | ₹1.3K Cr ▲55.3% | ₹839 Cr |
| Investments | ₹2.3K Cr ▲107.0% | ₹1.1K Cr ▲12.7% | ₹1.0K Cr ▼51.7% | ₹2.1K Cr ▲30.3% | ₹1.6K Cr ▼18.6% | ₹2.0K Cr ▲102.1% | ₹966 Cr ▼4.5% | ₹1.0K Cr ▲49.9% | ₹675 Cr ▼46.1% | ₹1.3K Cr |
| Other Assets | ₹18.5K Cr ▲9.3% | ₹16.9K Cr ▲5.1% | ₹16.1K Cr ▲25.1% | ₹12.9K Cr ▲59.6% | ₹8.1K Cr ▲9.5% | ₹7.4K Cr ▲39.6% | ₹5.3K Cr ▲9.8% | ₹4.8K Cr ▲11.6% | ₹4.3K Cr ▲17.3% | ₹3.7K Cr |
| Total Assets | ₹62.8K Cr ▲7.2% | ₹58.5K Cr ▲5.0% | ₹55.8K Cr ▲7.8% | ₹51.7K Cr ▲154.4% | ₹20.3K Cr ▲10.0% | ₹18.5K Cr ▲28.3% | ₹14.4K Cr ▲18.2% | ₹12.2K Cr ▲22.0% | ₹10.0K Cr ▲6.3% | ₹9.4K Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹4.1K Cr ▲37.5% | ₹3.0K Cr ▲59.5% | ₹1.9K Cr ▲57.3% | ₹1.2K Cr ▲1.5% | ₹1.2K Cr ▼9.6% | ₹1.3K Cr ▲11.1% | ₹1.2K Cr ▲74.5% | ₹662 Cr ▲3.4% | ₹640 Cr ▲72.5% | ₹371 Cr |
| Investing CF | ₹-203 Cr ▲79.7% | ₹-1.0K Cr ▲93.0% | ₹-14.3K Cr ▼758.0% | ₹-1.7K Cr ▲54.5% | ₹-3.7K Cr ▼142.6% | ₹-1.5K Cr ▼114.1% | ₹-703 Cr ▼2.8% | ₹-684 Cr ▼34.1% | ₹-510 Cr ▲55.2% | ₹-1.1K Cr |
| Financing CF | ₹-1.9K Cr ▲20.5% | ₹-2.3K Cr ▼117.9% | ₹13.0K Cr ▲5292.1% | ₹242 Cr ▼90.6% | ₹2.6K Cr ▲560.8% | ₹388 Cr ▲260.3% | ₹-242 Cr ▼0.8% | ₹-240 Cr ▼34.8% | ₹-178 Cr ▼116.7% | ₹1.1K Cr |
| Net Cash Flow | ₹2.0K Cr ▲627.4% | ₹-380 Cr ▼159.3% | ₹641 Cr ▲363.8% | ₹-243 Cr ▼437.5% | ₹72 Cr ▼56.4% | ₹165 Cr ▼21.4% | ₹210 Cr ▲180.5% | ₹-261 Cr ▼455.3% | ₹-47 Cr ▼115.7% | ₹300 Cr |
| Free Cash Flow | ₹1.7K Cr ▲64.2% | ₹1.0K Cr ▲710.9% | ₹129 Cr ▲117.3% | ₹-746 Cr ▼29.3% | ₹-577 Cr ▼5.7% | ₹-546 Cr ▼62.0% | ₹-337 Cr ▼34.3% | ₹-251 Cr ▼884.4% | ₹32 Cr ▲113.0% | ₹-246 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 131d ▼14.9% | 154d ▲31.6% | 117d ▲27.2% | 92d ▲19.5% | 77d ▲8.5% | 71d ▼17.4% | 86d ▼8.5% | 94d ▲13.3% | 83d ▲6.4% | 78d |
| Inventory Days | 346d ▼6.0% | 368d ▼13.0% | 423d ▲36.9% | 309d ▲1.6% | 304d ▲15.6% | 263d ▲32.2% | 199d ▲23.6% | 161d ▲0.6% | 160d ▲4.6% | 153d |
| Days Payable | 460d ▼1.5% | 467d ▲21.9% | 383d ▲77.3% | 216d ▼12.2% | 246d ▲1.2% | 243d ▲5.2% | 231d ▲3.1% | 224d ▲19.8% | 187d ▲8.7% | 172d |
| Cash Conv. Cycle | 18d ▼67.3% | 55d ▼65.0% | 157d ▼14.7% | 184d ▲37.3% | 134d ▲47.3% | 91d ▲71.7% | 53d ▲71.0% | 31d ▼45.6% | 57d ▼3.4% | 59d |
| Working Capital Days | -63d ▲7.4% | -68d ▼2366.7% | 3d ▼95.8% | 71d ▲787.5% | 8d ▲125.8% | -31d ▼1450.0% | -2d ▼133.3% | 6d ▼75.0% | 24d ▲300.0% | -12d |
| ROCE | 6.0% ▲0.0% | 6.0% ▲0.0% | 6.0% ▼33.3% | 9.0% ▼10.0% | 10.0% ▼23.1% | 13.0% ▲0.0% | 13.0% ▲62.5% | 8.0% ▼33.3% | 12.0% ▲33.3% | 9.0% |
Source: Screener.in · Lower days = better efficiency
Deep Dive Analysis
About Biocon Limited
Biocon is engaged in the business of manufacture of biotechnology products and research services.(Source : 202003-01 Annual Report Page No:195)
Healthcare · Pharmaceuticals & Biotechnology
Related Analysis
Frequently Asked Questions
What is Biocon Limited share price today?▾
Biocon Limited (BIOCON) is currently trading at ₹413.45 on NSE, as of the last market session. Prices update daily after market close on MarketNetra.
Is Biocon Limited available in F&O (Futures & Options)?▾
Yes, Biocon Limited (BIOCON) is part of the NSE F&O segment with a lot size of 2500 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Biocon Limited 52-week high and low?▾
Biocon Limited's 52-week high is ₹440 and the 52-week low is ₹328. The current price of ₹413.45 is 6.0% below the 52W high.
What is Biocon Limited P/E ratio?▾
Biocon Limited's current P/E ratio is 174. This indicates the market is paying ₹174 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Biocon Limited options?▾
Biocon Limited options are traded on NSE with monthly expiry contracts (lot size: 2500 shares). To trade BIOCON options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.